CCMRI
CLX icon

Core Capital Management & Research, inc.’s Clorox CLX Stock Holding History

Core Capital Management & Research, inc.’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Buy
+190
New +$18.2K 0.01% 142

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Core Capital Management & Research, inc.'s CLX Position: Q2 2026 in Review

Core Capital Management & Research, inc. opened a new position in Clorox (CLX) in Q2 2026: 190 shares worth $20.4K. The stake represents 0.01% of the portfolio and ranks #142 among its holdings.

1,048 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Core Capital Management & Research, inc. held 190 shares of Clorox worth $20.4K as of Q2 2026.
  • Clorox was a new Core Capital Management & Research, inc. position in Q2 2026.
  • Clorox made up 0.01% of Core Capital Management & Research, inc.'s portfolio in Q2 2026, its #142 holding.
  • 1,048 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Core Capital Management & Research, inc.'s 13F filing for Q2 2026, filed 9 Sep 2026.